Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Cay Uwe von Seydewitz, Jan Beneke et al.|BMJ|2012Cited by 309
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registryJan T. Kielstein, R. Brunkhorst, Gernot Beutel et al.|Nephrology Dialysis Transplantation|2012Cited by 239